EUVIMED · CrossrefZeitschrift
Biologics: Targets & Therapy
ISSN 1177-5475 · Informa UK Limited
Neueste Artikel
Hereditary angioedema: epidemiology, management, and role of icatibant
The role of epigenetic mechanisms and processes in autoimmune disorders
Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases
The molecular profile of luminal B breast cancer
Natural killer cells: role in local tumor growth and metastasis
Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
Small molecule tyrosine kinase inhibitors in pancreatic cancer
Novel microtubule-targeting agents – the epothilones
Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures
Front line treatment of elderly multiple myeloma in the era of novel agents
Botulinum toxin type A in the treatment of patients with cervical dystonia
Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
Current available therapies and future directions in the treatment of malignant gliomas
Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model
Maintenance treatment with infliximab for the management of Crohn’s disease in adults
Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia
Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
Biologic targeting in the treatment of inflammatory bowel diseases
Palifermin for management of treatment-induced oral mucositis in cancer patients
Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A
Challenges in the management of juvenile idiopathic arthritis with etanercept
Management of chronic hepatitis C treatment failures: role of consensus interferon
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
Ustekinumab in the therapy of chronic plaque psoriasis
Long-term pegylated interferon-α and its potential in the treatment of melanoma
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells
EUVIMED